Health Ministry confirms trials of Intranasal Covid vaccine in India

Health Minister Harsh Vardhan has said that the Serum Institute of India and Bharat Biotech will begin the last trial of the intranasal corona vaccine in the coming months in the country.

Health Ministry confirms trials of Intranasal Covid vaccine in India

Nasal Corona Vaccine (PC: Social Media)

New Delhi: The havoc of Corona virus epidemic in the country is now gradually decreasing. Meanwhile, many types of news are coming in the country about the Corona vaccine. The corona vaccine is expected to be introduced in the country by next year.

Trials of Nasal Vaccine in India:

Meanwhile, Health Minister Harsh Vardhan has said that the Serum Institute of India and Bharat Biotech will begin the last trial of the intranasal corona vaccine in the coming months in the country.

The Health Minister said that at present there is no trial of a single intranasal (nasal vaccine) corona vaccine in India. Clinical trials of such vaccines are likely to done after the approval of Serum Institute of India or Bharat Biotech in the coming months.

ALSO READ: Mayawati slams Congress leader Kamal Nath over his ‘Item’ remark

Health Minister Harsh Vardhan said that the final phase of testing usually involves thousands of participants. Sometimes there are 30,000 to 40,000 people as well. He said that no nasal vaccine currently tested in the country. This vaccine is given to people through the nose rather than by direct injection.

Corona havoc in winter season:

Scientists have predicted that corona infection may increase during the winter season. They say that a major reason for the corona virus to spread during the summer season is exposure to infected small sized aerosol particles (solid or vapor particles present in the air). Whereas, the main reason for spreading the infection in winter can be through direct contact with droplets coming out of the mouth and nose during exhalation, coughing or sneezing.

ALSO READ: Tension at Assam Mizoram Border: Many wounded in the violence

On October 13, the Hyderabad-based pharmaceutical firm re-applied to the Drugs Controller General of India (DCGI) and sought approval for simultaneous human trials of the second and third phase of the Russian corona vaccine Sputnik-V in the country.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on twitter.

Keep yourself updated with latest news through Newstrack App. To download App from Google Playstore visit here - Newstrack App